Opko Health
OPK
202 hedge funds and large institutions have $426M invested in Opko Health in 2018 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 52 increasing their positions, 63 reducing their positions, and 37 closing their positions.
3% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 37
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less funds holding
Funds holding: 203 → 202 (-1)
1.48% less ownership
Funds ownership: 26.94% → 25.46% (-1.5%)
17% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 63
19% less capital invested
Capital invested by funds: $526M → $426M (-$100M)
61% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $27.4M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$4.22M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.69M |
| 3 |
Millennium Management
New York
|
+$2.36M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.35M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$22.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.73M |
| 3 |
First Manhattan
New York
|
-$5.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.34M |
| 5 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
-$4.32M |
OPK Hedge Fund Activity: Q4 2018 in Review
202 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q4 2018, worth a combined $426M — down 19% from $526M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new OPK positions and 37 closed out — a net gain of 1 holder — while 52 added to existing stakes and 63 trimmed.
The largest buyer was Citigroup, adding an estimated $4.22M. The largest seller was State Street, cutting an estimated $22.7M.
- 202 institutional investors held Opko Health (OPK) as of Q4 2018, down from 203 in Q3 2018.
- Funds reported $426M of Opko Health stock for Q4 2018, down 19% quarter-over-quarter.
- 38 funds opened new Opko Health positions in Q4 2018 and 37 closed out, a net change of +1 holder.
- The largest Opko Health buyer in Q4 2018 was Citigroup, an estimated $4.22M added.
- The largest Opko Health seller in Q4 2018 was State Street, an estimated $22.7M sold.
Based on aggregated 13F filings for Q4 2018.